Pinetree Capital Ltd. (TSE:PNP – Get Free Report) insider L6 Holdings Inc. sold 3,000 shares of the business’s stock in a transaction on Friday, December 13th. The shares were sold at an average price of C$10.10, for a total transaction of C$30,300.00.
L6 Holdings Inc. also recently made the following trade(s):
- On Wednesday, December 11th, L6 Holdings Inc. sold 3,000 shares of Pinetree Capital stock. The shares were sold at an average price of C$11.53, for a total transaction of C$34,590.00.
- On Monday, December 9th, L6 Holdings Inc. sold 3,000 shares of Pinetree Capital stock. The shares were sold at an average price of C$12.56, for a total transaction of C$37,680.00.
- On Thursday, December 5th, L6 Holdings Inc. sold 3,076 shares of Pinetree Capital stock. The shares were sold at an average price of C$15.12, for a total transaction of C$46,506.04.
Pinetree Capital Price Performance
Shares of TSE PNP opened at C$10.10 on Friday. The firm has a market capitalization of C$94.84 million, a P/E ratio of 7.11 and a beta of 0.60. Pinetree Capital Ltd. has a one year low of C$3.46 and a one year high of C$15.43. The company’s fifty day moving average is C$9.73 and its two-hundred day moving average is C$7.65. The company has a debt-to-equity ratio of 0.35, a quick ratio of 5.97 and a current ratio of 8.14.
Pinetree Capital Company Profile
Pinetree Capital Ltd. is a venture capital and private equity firm specializing in early, later stage venture, middle market, mature, later stage, turnaround and growth capital investments in micro and small cap companies. The firm prefers to invest in enterprise software, financial and healthcare industries.
Further Reading
- Five stocks we like better than Pinetree Capital
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Investing in Construction Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Pinetree Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pinetree Capital and related companies with MarketBeat.com's FREE daily email newsletter.